SKM Egg Products Q1 FY26: ₹16 Cr Profit – The Yolk’s on Inflation!

SKM Egg Products Q1 FY26: ₹16 Cr Profit – The Yolk’s on Inflation!

At a Glance

SKM Egg Products just cracked open its Q1 FY26 numbers and—surprise!—the omelette didn’t flop. Sales jumped 49% YoY to ₹176 Cr, while net profit sizzled at ₹16 Cr, a 34% spike. EPS fried up to ₹6.18. Stock at ₹292 still trades at a P/E of 19.8x, giving poultry investors something to cluck about. Final dividend? ₹1.50 per share. Not bad for an egg business in a world that can’t decide between vegan and keto.


Introduction

Eggs are simple. SKM’s earnings? Not so much. From being an export-focused EOU making liquid egg mixes for bakeries and pharmaceuticals, this company has turned into a profit machine—at least when raw material prices don’t spoil the recipe. Q1 FY26 showed strong sales momentum after a patchy FY25, proving that even in tough markets, scrambled strategies can still yield sunny-side-up results.


Business Model (WTF Do They Even Do?)

  • Core Business: Processing and exporting egg products (powdered, liquid, albumen, yolk blends).
  • End Users: Bakery, confectionery, noodles, meat products, mayonnaise, pharmaceuticals.
  • Certifications: ISO, BRC, HALAL – basically the Michelin stars of food safety.

Roast: They turn eggs into everything except magic potions, yet still have to fight margin volatility like it’s a food fight.


Financials Overview

Q1 FY26

  • Revenue: ₹176 Cr (↑49% YoY)
  • Operating Profit: ₹25 Cr (OPM 14%)
  • PAT: ₹16 Cr (↑35% YoY)
  • EPS: ₹6.18

FY25

  • Revenue: ₹498 Cr
  • PAT: ₹35 Cr
  • ROE: 11.9%

Comment: YoY growth is egg-cellent, but quarterly volatility remains.


Valuation

  1. P/E Method
    • EPS TTM: ₹14.7
    • Sector P/E: 18x
    • Value ≈ ₹265
  2. Book Value
    • BV: ₹115
    • CMP/BV: 2.54x
    • Value ≈ ₹230
  3. EV/EBITDA
    • EBITDA TTM: ₹65 Cr
    • Multiple: 10x
    • Value ≈ ₹300

🎯 Fair Value Range: ₹230 – ₹300
CMP ₹292 → fully priced with little yolk left for upside.


What’s Cooking – News, Triggers, Drama

  • Dividend: ₹1.50/share announced.
  • Promoter Holding: Slightly up at 56.25% – promoters seem bullish.
  • Growth Trigger: Expansion in pharmaceutical-grade egg products.
  • Risks: Avian flu, feed cost spikes, currency fluctuations.

Balance Sheet

(₹ Cr)Mar 2025
Assets494
Liabilities217
Net Worth303
Borrowings149

Remark: Leverage manageable, reserves growing steadily.


Cash Flow – Sab Number Game Hai

(₹ Cr)FY23FY24FY25
Operating6010965
Investing-16-54-23
Financing-513-25

Remark: Healthy ops cash, investing outflows for expansion, debt reduction ongoing.


Ratios – Sexy or Stressy?

MetricValue
ROE11.9%
ROCE13.3%
P/E19.8x
PAT Margin9%
D/E0.49

Remark: Margins okay, valuation not cheap.


P&L Breakdown – Show Me the Money

(₹ Cr)FY23FY24FY25
Revenue662701498
EBITDA14415157
PAT768535

Remark: FY25 was a downturn, FY26 Q1 hints at revival.


Peer Comparison

CompanyRevenue (₹ Cr)PAT (₹ Cr)P/E
SKM Egg Prod.5563920x
Venky’s India3,30711718x
HMA Agro5,1338718x
Ovobel Foods189915x

Remark: SKM trades at a premium P/E despite smaller scale.


Miscellaneous – Shareholding, Promoters

  • Promoters: 56.3% (↑0.9% QoQ)
  • FIIs: 0.3%
  • Public: 43.5%

Observation: Promoter buying adds confidence.


EduInvesting Verdict™

SKM Egg Products is a niche exporter that has cracked the code of high-margin egg processing. However, volatile earnings and dependency on exports keep the risk omelette hot.

SWOT Quickie

  • Strengths: High profit CAGR, quality certifications, export niche.
  • Weaknesses: Small scale, earnings volatility.
  • Opportunities: Pharma-grade products, domestic expansion.
  • Threats: Bird flu, global demand shifts.

Final Word: A good stock for patient investors, but don’t put all your eggs in this basket.


Written by EduInvesting Team | 30 July 2025
SEO Tags: SKM Egg Products Q1 FY26 Results, SKM Eggs Analysis, Egg Export Industry India

Leave a Comment

Popular News

error: Content is protected !!
Scroll to Top